Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Editas Medicine (EDIT) Return on Assets: 2016-2025

Historic Return on Assets for Editas Medicine (EDIT) over the last 10 years, with Sep 2025 value amounting to -0.96%.

  • Editas Medicine's Return on Assets fell 37.00% to -0.96% in Q3 2025 from the same period last year, while for Sep 2025 it was -0.96%, marking a year-over-year decrease of 37.00%. This contributed to the annual value of -0.56% for FY2024, which is 26.00% down from last year.
  • Per Editas Medicine's latest filing, its Return on Assets stood at -0.96% for Q3 2025, which was up 3.13% from -0.99% recorded in Q2 2025.
  • Editas Medicine's 5-year Return on Assets high stood at -0.21% for Q1 2021, and its period low was -0.99% during Q2 2025.
  • Over the past 3 years, Editas Medicine's median Return on Assets value was -0.47% (recorded in 2024), while the average stood at -0.58%.
  • Its Return on Assets has fluctuated over the past 5 years, first increased by 12bps in 2023, then slumped by 52bps in 2025.
  • Over the past 5 years, Editas Medicine's Return on Assets (Quarterly) stood at -0.28% in 2021, then fell by 15bps to -0.42% in 2022, then climbed by 12bps to -0.30% in 2023, then slumped by 41bps to -0.71% in 2024, then plummeted by 37bps to -0.96% in 2025.
  • Its Return on Assets was -0.96% in Q3 2025, compared to -0.99% in Q2 2025 and -0.83% in Q1 2025.